title: Targeting TGF-beta overexpression: maximizing the antifibrotic actions of angiotensin II blockade in anti-Thy1 glomerulonephritis.
authors.affiliation: Division of Nephrology, University of Utah, Salt Lake City, USA.
authors.forename: H
authors.initials: H
authors.lastname: Peters
authors.forename: W A
authors.initials: WA
authors.lastname: Border
authors.forename: N A
authors.initials: NA
authors.lastname: Noble
mesh_terms: D000804:Angiotensin II / Q000037:antagonists & inhibitors*; D000818:Animals; D004656:Enalapril / Q000627:therapeutic use; D005921:Glomerulonephritis / Q000188:drug therapy*; D019808:Losartan / Q000627:therapeutic use; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D018800:Thy-1 Antigens / Q000276:immunology*; D016212:Transforming Growth Factor beta / Q000096:biosynthesis*
chemical_list: D018800:Thy-1 Antigens; D016212:Transforming Growth Factor beta; D000804:Angiotensin II; D004656:Enalapril; D019808:Losartan